Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Kendall, S. Schumacher, C. Denkinger, D. Dowdy (2017)
Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling studyPLoS Medicine, 14
C. Denkinger, S. Kik, D. Cirillo, M. Casenghi, T. Shinnick, K. Weyer, C. Gilpin, C. Boehme, M. Schito, M. Kimerling, M. Pai (2015)
Defining the needs for next generation assays for tuberculosis.The Journal of infectious diseases, 211 Suppl 2
Cazabon (2018)
Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: a trend analysis from 2014–2016Gates Open Res, 2
K. Steingart, Ian Schiller, D. Horne, M. Pai, C. Boehme, N. Dendukuri (2014)
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsThe Cochrane Database of Systematic Reviews, 2014
P. Escalante (1904)
TuberculosisThe Hospital, 36
Yingda Xie, S. Chakravorty, D. Armstrong, S. Hall, L. Via, T. Song, Xing Yuan, Xiaoying Mo, H. Zhu, P. Xu, Q. Gao, Myung‐hee Lee, Jongseok Lee, Laura Smith, Ray Chen, J. Joh, Youngsoo Cho, Xin Liu, Xianglin Ruan, L. Liang, N. Dharan, Sang-Nae Cho, C. Barry, J. Ellner, S. Dorman, D. Alland (2017)
Evaluation of a Rapid Molecular Drug‐Susceptibility Test for TuberculosisThe New England Journal of Medicine, 377
R. Subbaraman, R. Nathavitharana, S. Satyanarayana, M. Pai, B. Thomas, V. Chadha, K. Rade, S. Swaminathan, K. Mayer (2016)
The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysisPLoS Medicine, 13
M. Nash, S. Huddart, Sayema Badar, S. Baliga, K. Saravu, M. Pai (2018)
Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysisJournal of Clinical Microbiology, 56
L. Paris, R. Magni, Fatima Zaidi, R. Araujo, Neal Saini, M. Harpole, J. Coronel, D. Kirwan, H. Steinberg, R. Gilman, E. Petricoin, R. Nisini, A. Luchini, L. Liotta (2017)
Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severityScience Translational Medicine, 9
Zibusiso Ndlovu, E. Fajardo, E. Mbofana, T. Maparo, D. Garone, C. Metcalf, H. Bygrave, K. Kao, S. Zinyowera (2018)
Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural ZimbabwePLoS ONE, 13
L. Fenner, M. Ballif, C. Graber, Venerandah Nhandu, J. Dusingize, C. Cortes, G. Carriquiry, K. Anastos, D. Garone, E. Jong, J. Gnokoro, O. Sued, S. Ajayi, L. Diero, K. Wools-Kaloustian, S. Kiertiburanakul, B. Castelnuovo, C. Lewden, N. Durier, T. Sterling, M. Egger (2013)
Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and ScreeningPLoS ONE, 8
M. Pai, J. Furin (2017)
Tuberculosis innovations mean little if they cannot save liveseLife, 6
L. Fenner, S. Gagneux, J. Janssens, J. Fehr, M. Cavassini, M. Hoffmann, E. Bernasconi, J. Schrenzel, T. Bodmer, E. Böttger, P. Helbling, M. Egger (2012)
Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment OutcomesPLoS ONE, 7
Danielle Cazabon, T. Pande, S. Kik, W. Gemert, H. Sohn, C. Denkinger, Z. Qin, B. Waning, M. Pai (2018)
Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016Gates Open Research, 2
J. Cox, R. Lukande, S. Kalungi, E. Marck, K. Vijver, A. Kambugu, A. Nelson, R. Colebunders, Y. Manabe (2015)
Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected AdultsPLoS ONE, 10
A. Detjen, A. DiNardo, J. Leyden, K. Steingart, D. Menzies, Ian Schiller, N. Dendukuri, A. Mandalakas (2015)
Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis.The Lancet. Respiratory medicine, 3 6
E. MacLean, M. Pai (2018)
Urine Lipoarabinomannan for Tuberculosis Diagnosis: Evolution and Prospects.Clinical chemistry, 64 8
R. Nathavitharana, P. Cudahy, S. Schumacher, K. Steingart, M. Pai, C. Denkinger (2017)
Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysisThe European Respiratory Journal, 49
R. Nathavitharana, M. Pai (2018)
New strategies for inpatients with HIV and tuberculosisLancet, 392 10144
A. Gupta-Wright, Jurgens Peters, C. Flach, S. Lawn (2016)
Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysisBMC Medicine, 14
J. Peter, L. Zijenah, D. Chanda, P. Clowes, K. Dheda (2016)
Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trialThe Lancet, 387
A. Gupta-Wright, E. Corbett, J. Oosterhout, D. Wilson, D. Grint, Melanie Alufandika-Moyo, Jurgens Peters, L. Chiume, C. Flach, S. Lawn, K. Fielding (2018)
Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trialLancet (London, England), 392
Rishi Gupta, S. Lucas, K. Fielding, S. Lawn (2015)
Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysisAIDS (London, England), 29
Mikashmi Kohli, K. Walia, S. Mazumdar, C. Boehme, Zachary Katz, M. Pai (2018)
Availability of essential diagnostics in primary care in India.The Lancet. Infectious diseases, 18 10
J. Levi, Alice Raymond, A. Pozniak, P. Vernazza, P. Kohler, A. Hill (2016)
Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascadesBMJ Global Health, 1
A. Luetkemeyer, M. Kendall, Xingye Wu, M. Lourenço, U. Jentsch, S. Swindells, S. Qasba, Jorge Sanchez, D. Havlir, B. Grinsztejn, I. Sanne, C. Firnhaber (2014)
Evaluation of Two Line Probe Assays for Rapid Detection of Mycobacterium tuberculosis, Tuberculosis (TB) Drug Resistance, and Non-TB Mycobacteria in HIV-Infected Individuals with Suspected TBJournal of Clinical Microbiology, 52
P. Drain, Lilishia Gounder, F. Sahid, M. Moosa (2016)
Rapid Urine LAM Testing Improves Diagnosis of Expectorated Smear-Negative Pulmonary Tuberculosis in an HIV-endemic RegionScientific Reports, 6
L. Nakiyingi, W. Ssengooba, D. Nakanjako, D. Armstrong, Molly Holshouser, B. Kirenga, M. Shah, H. Mayanja-Kizza, M. Joloba, J. Ellner, S. Dorman, Y. Manabe (2015)
Predictors and outcomes of mycobacteremia among HIV-infected smear- negative presumptive tuberculosis patients in UgandaBMC Infectious Diseases, 15
S. Huddart, E. MacLean, M. Pai (2016)
Location, location, location: tuberculosis services in highest burden countries.The Lancet. Global health, 4 12
Marais Bj, A. Hesseling, R. Gie, H. Schaaf, D. Enarson, N. Beyers (2006)
The bacteriologic yield in children with intrathoracic tuberculosis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 42 8
K. Weyer, F. Mirzayev, G. Migliori, W. Gemert, L. D’Ambrosio, M. Zignol, K. Floyd, R. Centis, D. Cirillo, E. Tortoli, C. Gilpin, Jean Iragena, D. Falzon, M. Raviglione (2012)
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIFEuropean Respiratory Journal, 42
Robyn Lee, M. Pai (2017)
Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?Journal of Clinical Microbiology, 55
P. Drain, K. Bajema, D. Dowdy, K. Dheda, K. Naidoo, S. Schumacher, Shuyi Ma, Erin Meermeier, D. Lewinsohn, D. Sherman (2018)
Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of InfectionClinical Microbiology Reviews, 31
Jingwen Ai, Qiaoling Ruan, Qi-hui Liu, Wenhong Zhang (2016)
Updates on the risk factors for latent tuberculosis reactivation and their managementsEmerging Microbes & Infections, 5
K. Clouse, Meridith Blevins, M. Lindegren, M. Yotebieng, Dung Nguyen, Alfred Omondi, D. Michael, D. Zannou, G. Carriquiry, A. Pettit (2017)
Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) programPLoS ONE, 12
P. Naidoo, G. Theron, M. Rangaka, V. Chihota, L. Vaughan, Z. Brey, Y. Pillay (2017)
The South African Tuberculosis Care Cascade: Estimated Losses and Methodological ChallengesThe Journal of Infectious Diseases, 216
M. Shah, C. Hanrahan, Z. Wang, N. Dendukuri, S. Lawn, C. Denkinger, K. Steingart (2016)
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adultsThe Cochrane Database of Systematic Reviews, 2016
M. Nash, J. Ramapuram, Ramya Kaiya, S. Huddart, M. Pai, S. Baliga (2017)
Use of the GeneXpert tuberculosis system for HIV viral load testing in India.The Lancet. Global health, 5 8
D. Lanjewar (2011)
The Spectrum of Clinical and Pathological Manifestations of AIDS in a Consecutive Series of 236 Autopsied Cases in Mumbai, IndiaPathology Research International, 2011
H. Getahun, M. Harrington, Rick O'Brien, P. Nunn (2007)
Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changesThe Lancet, 369
Danielle Cazabon, H. Alsdurf, S. Satyanarayana, R. Nathavitharana, R. Subbaraman, A. Daftary, M. Pai (2017)
Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 56
Purpose of review Diagnosis of tuberculosis (TB) in people living with HIV (PLHIV) remains a challenge, despite it being the most common comorbidity in this group. In this review, we provide an overview of tests for active TB, and their diagnostic performance in PLHIV. Recent findings New and updated diagnostic tests have better performance than traditional bacterial culture or smear microscopy in PLHIV. Recent developments in molecular tests have improved the sensitivity at which TB and drug susceptibility can be detected in PLHIV. Notably, the updated Xpert Ultra test can detect HIV-associated TB with high sensitivity, and a rapid lateral flow lipoarabinomannan-based assay has been shown to reduce TB-related mortality in hospitalized PLHIV. New directions in drug-susceptibility testing are being pursued, such as next-generation sequencing and line probe assays, but more evaluation in PLHIV is needed. There is growing understanding of subclinical TB, but methods to detect this type of TB are inadequate. Summary As diagnosis is the weakest link in the TB care cascade, newer more accurate TB tests must be scaled up and fully integrated into existing healthcare systems. Drug-susceptibility testing must become universal to ensure appropriate treatment regimens are prescribed, allowing TB clearance and inhibiting development of antimicrobial resistance.
Current Opinion in HIV and AIDS – Wolters Kluwer Health
Published: Jan 1, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.